Characterization of putative Japanese encephalitis virus receptor molecules on microglial cells

Thananya Thongtan1, Nitwara Wikan, Phitchayapak Wintachai

  • 1Department of Biochemistry, Chulalongkorn University, Bangkok, Thailand.

Journal of Medical Virology
|February 17, 2012
PubMed

Insights

Japanese encephalitis virus (JEV) enters microglial cells via multiple receptors. CD4 plays a significant role in JEV entry, highlighting potential therapeutic targets for viral encephalitis.

Area of Science:

  • Neurovirology
  • Immunology

Background:

  • Japanese encephalitis virus (JEV) causes viral encephalitis in Asia.
  • Microglia, immune cells in the central nervous system, may act as JEV reservoirs.
  • Viral entry into host cells is crucial for tissue tropism.

Purpose of the Study:

  • Identify molecules involved in JEV entry into microglial cells.
  • Investigate the role of candidate receptor proteins in JEV infection of microglia.

Main Methods:

  • Virus overlay protein-binding assay (VOPBA) and liquid chromatography-mass spectrometry (LC/MS/MS) identified JEV-binding proteins.
  • Antibody-mediated inhibition assays tested the role of candidate receptors (laminin receptor, nucleolin, Hsp70, Hsp90, GRP78, CD14, CD4) in JEV entry.
  • Lipopolysaccharide (LPS) was used to modulate CD4 and CD14 expression.

Main Results:

  • The 37/67 kDa high-affinity laminin receptor and nucleolin were identified as potential JEV-binding proteins.
  • Anti-laminin receptor and anti-CD4 antibodies significantly reduced JEV entry into microglial cells.
  • LPS treatment inhibited JEV entry by up to 80%, down-regulating CD4 and CD14 expression.

Conclusions:

  • Multiple receptor proteins mediate JEV entry into microglial cells.
  • CD4 plays a major role in JEV entry into microglia.
  • Targeting these receptors may offer therapeutic strategies against JEV infection.